IBDEI1NV ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,26528,0)
;;=H0015^^108^1248^4^^^^1
;;^UTILITY(U,$J,358.3,26528,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,26528,1,2,0)
;;=2^H0015
;;^UTILITY(U,$J,358.3,26528,1,3,0)
;;=3^ALCOH AND/OR DRUG SVCS;INTEN OPT TX,PER DAY
;;^UTILITY(U,$J,358.3,26529,0)
;;=G0176^^108^1248^1^^^^1
;;^UTILITY(U,$J,358.3,26529,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,26529,1,2,0)
;;=2^G0176
;;^UTILITY(U,$J,358.3,26529,1,3,0)
;;=3^ACTIVITY TX R/T CARE & TX OF DISABILING MH PROBLEMS,45+ MIN
;;^UTILITY(U,$J,358.3,26530,0)
;;=G0177^^108^1248^32^^^^1
;;^UTILITY(U,$J,358.3,26530,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,26530,1,2,0)
;;=2^G0177
;;^UTILITY(U,$J,358.3,26530,1,3,0)
;;=3^MH EDUC & TRAIN SVCS R/T CARE & TX OF DISABILING MH PROBLEM,45+ MIN
;;^UTILITY(U,$J,358.3,26531,0)
;;=Q3014^^108^1248^59^^^^1
;;^UTILITY(U,$J,358.3,26531,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,26531,1,2,0)
;;=2^Q3014
;;^UTILITY(U,$J,358.3,26531,1,3,0)
;;=3^TELEHEALTH FACILITY FEE
;;^UTILITY(U,$J,358.3,26532,0)
;;=99078^^108^1248^18^^^^1
;;^UTILITY(U,$J,358.3,26532,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,26532,1,2,0)
;;=2^99078
;;^UTILITY(U,$J,358.3,26532,1,3,0)
;;=3^GROUP HEALTH EDUCATION/COUNSELING
;;^UTILITY(U,$J,358.3,26533,0)
;;=S9446^^108^1248^41^^^^1
;;^UTILITY(U,$J,358.3,26533,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,26533,1,2,0)
;;=2^S9446
;;^UTILITY(U,$J,358.3,26533,1,3,0)
;;=3^PT EDUCATION NOS,GROUP NON-PHYS
;;^UTILITY(U,$J,358.3,26534,0)
;;=S9445^^108^1248^42^^^^1
;;^UTILITY(U,$J,358.3,26534,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,26534,1,2,0)
;;=2^S9445
;;^UTILITY(U,$J,358.3,26534,1,3,0)
;;=3^PT EDUCATION NOS,INDIV NON-PHYS
;;^UTILITY(U,$J,358.3,26535,0)
;;=98960^^108^1248^54^^^^1
;;^UTILITY(U,$J,358.3,26535,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,26535,1,2,0)
;;=2^98960
;;^UTILITY(U,$J,358.3,26535,1,3,0)
;;=3^SELF-MGMT EDUC/TRAIN,INDIV,EA 30 MIN
;;^UTILITY(U,$J,358.3,26536,0)
;;=96127^^108^1248^8^^^^1
;;^UTILITY(U,$J,358.3,26536,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,26536,1,2,0)
;;=2^96127
;;^UTILITY(U,$J,358.3,26536,1,3,0)
;;=3^BRIEF EMOTION/BEHAV ASSMT W/ SCORE & DOCUM
;;^UTILITY(U,$J,358.3,26537,0)
;;=G0175^^108^1248^29^^^^1
;;^UTILITY(U,$J,358.3,26537,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,26537,1,2,0)
;;=2^G0175
;;^UTILITY(U,$J,358.3,26537,1,3,0)
;;=3^INTERDISC CONF W/ PT,MINIMUM 3 STAFF
;;^UTILITY(U,$J,358.3,26538,0)
;;=H0006^^108^1248^17^^^^1
;;^UTILITY(U,$J,358.3,26538,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,26538,1,2,0)
;;=2^H0006
;;^UTILITY(U,$J,358.3,26538,1,3,0)
;;=3^ETOH/DRUG CASE MGMT
;;^UTILITY(U,$J,358.3,26539,0)
;;=H0047^^108^1248^58^^^^1
;;^UTILITY(U,$J,358.3,26539,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,26539,1,2,0)
;;=2^H0047
;;^UTILITY(U,$J,358.3,26539,1,3,0)
;;=3^SUBSTANCE USE SVCS,NOS
;;^UTILITY(U,$J,358.3,26540,0)
;;=H0039^^108^1248^6^^^^1
;;^UTILITY(U,$J,358.3,26540,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,26540,1,2,0)
;;=2^H0039
;;^UTILITY(U,$J,358.3,26540,1,3,0)
;;=3^ASSERTIVE COMMUNITY TX,F2F,PER 15 MIN
;;^UTILITY(U,$J,358.3,26541,0)
;;=H0040^^108^1248^5^^^^1
;;^UTILITY(U,$J,358.3,26541,1,0)
;;=^358.31IA^3^2
;;^UTILITY(U,$J,358.3,26541,1,2,0)
;;=2^H0040
;;^UTILITY(U,$J,358.3,26541,1,3,0)
;;=3^ASSERTIVE COMMUNITY TX PROG,PER DIEM
;;^UTILITY(U,$J,358.3,26542,0)
;;=H0036^^108^1248^10^^^^1
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI1NV 3782 printed Sep 23, 2025@19:48:22 Page 2
IBDEI1NV ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,26528,0)
+2 ;;=H0015^^108^1248^4^^^^1
+3 ;;^UTILITY(U,$J,358.3,26528,1,0)
+4 ;;=^358.31IA^3^2
+5 ;;^UTILITY(U,$J,358.3,26528,1,2,0)
+6 ;;=2^H0015
+7 ;;^UTILITY(U,$J,358.3,26528,1,3,0)
+8 ;;=3^ALCOH AND/OR DRUG SVCS;INTEN OPT TX,PER DAY
+9 ;;^UTILITY(U,$J,358.3,26529,0)
+10 ;;=G0176^^108^1248^1^^^^1
+11 ;;^UTILITY(U,$J,358.3,26529,1,0)
+12 ;;=^358.31IA^3^2
+13 ;;^UTILITY(U,$J,358.3,26529,1,2,0)
+14 ;;=2^G0176
+15 ;;^UTILITY(U,$J,358.3,26529,1,3,0)
+16 ;;=3^ACTIVITY TX R/T CARE & TX OF DISABILING MH PROBLEMS,45+ MIN
+17 ;;^UTILITY(U,$J,358.3,26530,0)
+18 ;;=G0177^^108^1248^32^^^^1
+19 ;;^UTILITY(U,$J,358.3,26530,1,0)
+20 ;;=^358.31IA^3^2
+21 ;;^UTILITY(U,$J,358.3,26530,1,2,0)
+22 ;;=2^G0177
+23 ;;^UTILITY(U,$J,358.3,26530,1,3,0)
+24 ;;=3^MH EDUC & TRAIN SVCS R/T CARE & TX OF DISABILING MH PROBLEM,45+ MIN
+25 ;;^UTILITY(U,$J,358.3,26531,0)
+26 ;;=Q3014^^108^1248^59^^^^1
+27 ;;^UTILITY(U,$J,358.3,26531,1,0)
+28 ;;=^358.31IA^3^2
+29 ;;^UTILITY(U,$J,358.3,26531,1,2,0)
+30 ;;=2^Q3014
+31 ;;^UTILITY(U,$J,358.3,26531,1,3,0)
+32 ;;=3^TELEHEALTH FACILITY FEE
+33 ;;^UTILITY(U,$J,358.3,26532,0)
+34 ;;=99078^^108^1248^18^^^^1
+35 ;;^UTILITY(U,$J,358.3,26532,1,0)
+36 ;;=^358.31IA^3^2
+37 ;;^UTILITY(U,$J,358.3,26532,1,2,0)
+38 ;;=2^99078
+39 ;;^UTILITY(U,$J,358.3,26532,1,3,0)
+40 ;;=3^GROUP HEALTH EDUCATION/COUNSELING
+41 ;;^UTILITY(U,$J,358.3,26533,0)
+42 ;;=S9446^^108^1248^41^^^^1
+43 ;;^UTILITY(U,$J,358.3,26533,1,0)
+44 ;;=^358.31IA^3^2
+45 ;;^UTILITY(U,$J,358.3,26533,1,2,0)
+46 ;;=2^S9446
+47 ;;^UTILITY(U,$J,358.3,26533,1,3,0)
+48 ;;=3^PT EDUCATION NOS,GROUP NON-PHYS
+49 ;;^UTILITY(U,$J,358.3,26534,0)
+50 ;;=S9445^^108^1248^42^^^^1
+51 ;;^UTILITY(U,$J,358.3,26534,1,0)
+52 ;;=^358.31IA^3^2
+53 ;;^UTILITY(U,$J,358.3,26534,1,2,0)
+54 ;;=2^S9445
+55 ;;^UTILITY(U,$J,358.3,26534,1,3,0)
+56 ;;=3^PT EDUCATION NOS,INDIV NON-PHYS
+57 ;;^UTILITY(U,$J,358.3,26535,0)
+58 ;;=98960^^108^1248^54^^^^1
+59 ;;^UTILITY(U,$J,358.3,26535,1,0)
+60 ;;=^358.31IA^3^2
+61 ;;^UTILITY(U,$J,358.3,26535,1,2,0)
+62 ;;=2^98960
+63 ;;^UTILITY(U,$J,358.3,26535,1,3,0)
+64 ;;=3^SELF-MGMT EDUC/TRAIN,INDIV,EA 30 MIN
+65 ;;^UTILITY(U,$J,358.3,26536,0)
+66 ;;=96127^^108^1248^8^^^^1
+67 ;;^UTILITY(U,$J,358.3,26536,1,0)
+68 ;;=^358.31IA^3^2
+69 ;;^UTILITY(U,$J,358.3,26536,1,2,0)
+70 ;;=2^96127
+71 ;;^UTILITY(U,$J,358.3,26536,1,3,0)
+72 ;;=3^BRIEF EMOTION/BEHAV ASSMT W/ SCORE & DOCUM
+73 ;;^UTILITY(U,$J,358.3,26537,0)
+74 ;;=G0175^^108^1248^29^^^^1
+75 ;;^UTILITY(U,$J,358.3,26537,1,0)
+76 ;;=^358.31IA^3^2
+77 ;;^UTILITY(U,$J,358.3,26537,1,2,0)
+78 ;;=2^G0175
+79 ;;^UTILITY(U,$J,358.3,26537,1,3,0)
+80 ;;=3^INTERDISC CONF W/ PT,MINIMUM 3 STAFF
+81 ;;^UTILITY(U,$J,358.3,26538,0)
+82 ;;=H0006^^108^1248^17^^^^1
+83 ;;^UTILITY(U,$J,358.3,26538,1,0)
+84 ;;=^358.31IA^3^2
+85 ;;^UTILITY(U,$J,358.3,26538,1,2,0)
+86 ;;=2^H0006
+87 ;;^UTILITY(U,$J,358.3,26538,1,3,0)
+88 ;;=3^ETOH/DRUG CASE MGMT
+89 ;;^UTILITY(U,$J,358.3,26539,0)
+90 ;;=H0047^^108^1248^58^^^^1
+91 ;;^UTILITY(U,$J,358.3,26539,1,0)
+92 ;;=^358.31IA^3^2
+93 ;;^UTILITY(U,$J,358.3,26539,1,2,0)
+94 ;;=2^H0047
+95 ;;^UTILITY(U,$J,358.3,26539,1,3,0)
+96 ;;=3^SUBSTANCE USE SVCS,NOS
+97 ;;^UTILITY(U,$J,358.3,26540,0)
+98 ;;=H0039^^108^1248^6^^^^1
+99 ;;^UTILITY(U,$J,358.3,26540,1,0)
+100 ;;=^358.31IA^3^2
+101 ;;^UTILITY(U,$J,358.3,26540,1,2,0)
+102 ;;=2^H0039
+103 ;;^UTILITY(U,$J,358.3,26540,1,3,0)
+104 ;;=3^ASSERTIVE COMMUNITY TX,F2F,PER 15 MIN
+105 ;;^UTILITY(U,$J,358.3,26541,0)
+106 ;;=H0040^^108^1248^5^^^^1
+107 ;;^UTILITY(U,$J,358.3,26541,1,0)
+108 ;;=^358.31IA^3^2
+109 ;;^UTILITY(U,$J,358.3,26541,1,2,0)
+110 ;;=2^H0040
+111 ;;^UTILITY(U,$J,358.3,26541,1,3,0)
+112 ;;=3^ASSERTIVE COMMUNITY TX PROG,PER DIEM
+113 ;;^UTILITY(U,$J,358.3,26542,0)
+114 ;;=H0036^^108^1248^10^^^^1
